<p>AMB – amphotericin B. The MICs of SM21 against the <i>Candida</i> isolates tested ranged from 0.2 – 1.6 µg/ml, while the MICs of amphotericin B ranged from 0.2 – 0.8 µg/ml. The similar range of MICs suggested the comparable potency of SM21 and amphotericin B. For the other fungal species, lower susceptibility of SM21 against <i>A. fumigatus</i> was observed. Such trend was also observed for amphotericin B.</p
A clear understanding of the pharmacodynamic properties of antifungal agents is important for the ad...
AbstractThe European Committee on Antimicrobial Susceptibility Testing-Subcommittee on Antifungal Su...
Conventional MIC testing of amphotericin B results in narrowMIC ranges challenging the detection of ...
There is little information addressing the phenomena of discrepancy between minimal inhibitory conce...
Introduction: Amphotericin B (AMB) is an antifungal agent used extensively in clinical medicine, yet...
Candida auris is an emerging multiresistant yeast against which amphotericin B (AMB) is still the fi...
International audienceRecent studies have shown decreased susceptibility of Candida krusei to amphot...
Introduction Amphotericin B (AMB) is an antifungal agent used extensively in clinical medicine,...
Conventional MIC testing of amphotericin B results in narrow MIC ranges challenging the detection of...
The antifungal susceptibilities of 598 isolates of Candida spp. (bloodstream, other sterile sites) t...
We determined the in vitro antifungal activity of liposomal amphotericin B (L-AmB) against 604 clini...
We investigated the fungicidal activity of caspofungin (CAS) and amphotericin B (AMB) against 16 cli...
We determined the in vitro antifungal activity of liposomal amphotericin B (L-AmB) against 604 clini...
This study evaluates the susceptibility of sucrose-negative Candida tropicalis and Candida lusitania...
Toxicity and failure of treatment with amphotericin B are stimuli for researchers to evaluate altern...
A clear understanding of the pharmacodynamic properties of antifungal agents is important for the ad...
AbstractThe European Committee on Antimicrobial Susceptibility Testing-Subcommittee on Antifungal Su...
Conventional MIC testing of amphotericin B results in narrowMIC ranges challenging the detection of ...
There is little information addressing the phenomena of discrepancy between minimal inhibitory conce...
Introduction: Amphotericin B (AMB) is an antifungal agent used extensively in clinical medicine, yet...
Candida auris is an emerging multiresistant yeast against which amphotericin B (AMB) is still the fi...
International audienceRecent studies have shown decreased susceptibility of Candida krusei to amphot...
Introduction Amphotericin B (AMB) is an antifungal agent used extensively in clinical medicine,...
Conventional MIC testing of amphotericin B results in narrow MIC ranges challenging the detection of...
The antifungal susceptibilities of 598 isolates of Candida spp. (bloodstream, other sterile sites) t...
We determined the in vitro antifungal activity of liposomal amphotericin B (L-AmB) against 604 clini...
We investigated the fungicidal activity of caspofungin (CAS) and amphotericin B (AMB) against 16 cli...
We determined the in vitro antifungal activity of liposomal amphotericin B (L-AmB) against 604 clini...
This study evaluates the susceptibility of sucrose-negative Candida tropicalis and Candida lusitania...
Toxicity and failure of treatment with amphotericin B are stimuli for researchers to evaluate altern...
A clear understanding of the pharmacodynamic properties of antifungal agents is important for the ad...
AbstractThe European Committee on Antimicrobial Susceptibility Testing-Subcommittee on Antifungal Su...
Conventional MIC testing of amphotericin B results in narrowMIC ranges challenging the detection of ...